| pph {causalOT} | R Documentation |
An external control trial of treatments for post-partum hemorrhage
Description
A dataset evaluating treatments for post-partum hemorrhage. The data contain treatment groups receiving misoprostol vs potential controls from other locations that received only oxytocin. The data is stored as a numeric matrix.
Usage
data(pph)
Format
A matrix with 802 rows and 17 variables
Details
The variables are as follows:
cum_blood_20m. The outcome variable denoting cumulative blood loss in mL 20 minutes after the diagnosis of post-partum hemorrhage (650 – 2000).
tx. The treatment indicator of whether an individual received misoprostol (1) or oxytocin (0).
age. the mother's age in years (15 – 43).
no_educ. whether a woman had no education (1) or some education (0).
num_livebirth. the number of previous live births.
cur_married. whether a mother is currently married (1 = yes, 0 = no).
gest_age. the gestational age of the fetus in weeks (35 – 43).
prev_pphyes. whether the woman has had a previous post-partum hemorrahge.
hb_test. the woman's hemoglobin in mg/dL (7 – 15).
induced_laboryes. whether labor was induced (1 = yes, 0 = no).
augmented_laboryes. whether labor was augmented (1 = yes, 0 = no).
early_cordclampyes. whether the umbilical cord was clamped early (1 = yes, 0 = no).
control_cordtractionyes. whether cord traction was controlled (1 = yes, 0 = no).
uterine_massageyes. whether a uterine massage was given (1 = yes, 0 = no).
placenta. whether placenta was delivered before treatment given (1 = yes, 0 = no).
bloodlossattx. amount of blood lost when treatment given (500 mL – 1800 mL)
sitecode. Which site is the individual from? (1 = Cairo, Egypt, 2 = Turkey, 3 = Hocmon, Vietnam, 4 = Cuchi, Vietnam, and 5 Burkina Faso).
Source
Data from the following Harvard Dataverse:
Winikoff, Beverly, 2019, "Two randomized controlled trials of misoprostol for the treatment of postpartum hemorrhage", https://doi.org/10.7910/DVN/ETHH4N, Harvard Dataverse, V1.
The data was originally analyzed in
Blum, J. et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. The Lancet 375, 217–223 (2010).